Skandinaviska Enskilda Banken AB (publ) - AGIOS PHARMACEUTICALS INC ownership

AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 162 filers reported holding AGIOS PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 1.92 and the average weighting 0.1%.

Quarter-by-quarter ownership
Skandinaviska Enskilda Banken AB (publ) ownership history of AGIOS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$1,543
+85.0%
62,360
+112.4%
0.01%
+100.0%
Q2 2023$834
+23.6%
29,3600.0%0.01%0.0%
Q1 2023$675
-22.0%
29,360
-4.6%
0.01%
-28.6%
Q4 2022$865
-99.9%
30,763
-5.5%
0.01%0.0%
Q3 2022$920,000
+27.6%
32,5450.0%0.01%
+40.0%
Q2 2022$721,000
-23.7%
32,5450.0%0.01%
-16.7%
Q1 2022$945,000
-13.4%
32,5450.0%0.01%0.0%
Q4 2021$1,091,000
-27.4%
32,5450.0%0.01%
-25.0%
Q3 2021$1,502,000
-16.2%
32,5450.0%0.01%
-27.3%
Q2 2021$1,793,000
+6.9%
32,5450.0%0.01%0.0%
Q1 2021$1,677,00032,5450.01%
Other shareholders
AGIOS PHARMACEUTICALS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Rock Springs Capital Management LP 3,057,869$86,477,0002.23%
Eagle Health Investments LP 329,713$9,324,0002.14%
Bellevue Group AG 4,058,792$114,783,0001.65%
SUVRETTA CAPITAL MANAGEMENT, LLC 959,214$27,127,0001.13%
ARMISTICE CAPITAL, LLC 1,924,000$54,411,0000.94%
Integral Health Asset Management, LLC 100,000$2,828,0000.55%
Monarch Partners Asset Management LLC 57,820$1,635,0000.49%
ArrowMark Colorado Holdings LLC 1,380,389$39,037,0000.48%
AlphaCentric Advisors LLC 15,000$424,0000.44%
PDT Partners, LLC 72,778$2,058,0000.31%
View complete list of AGIOS PHARMACEUTICALS INC shareholders